Japanese Pharmaceutical Regulations of Engineered Viral Vectors for Medical Use Compared With Those in the United States and the European Union

Clin Pharmacol Ther. 2023 May;113(5):960-962. doi: 10.1002/cpt.2788. Epub 2022 Nov 20.

Authors

Akira Sakurai¹, Seiichi Kanzaki², Futaba Honda²

Affiliations

¹ Center for Product Evaluation, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
² Office of Cellular and Tissue-based Products, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

PMID: 36404404
DOI: 10.1002/cpt.2788

No abstract available

MeSH terms

Drug Industry* / legislation & jurisprudence
European Union
Japan
Pharmaceutical Preparations
Pharmacy*
United States
Viruses*

Substances

Pharmaceutical Preparations